Profile
S.
George Simon is currently working as a Director at Omixon Biocomputing Kft.
Prior to this, he worked as the President & Chief Executive Officer at MediProPharma, Inc. He also worked as the Vice President-Business Development at Myriad Genetics, Inc. and Tute Genomics, Inc.
S. George Simon active positions
| Companies | Position | Start |
|---|---|---|
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Operates molecular diagnostics company that develops and commercializes disruptive technologies for clinical & research laboratories | Director/Board Member | - |
Former positions of S. George Simon
| Companies | Position | End |
|---|---|---|
MediProPharma, Inc.
MediProPharma, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Chief Executive Officer | - |
Tute Genomics, Inc.
Tute Genomics, Inc. Packaged SoftwareTechnology Services Develops and provides cloud-based application that delivers genomic insights to genetics research, clinicians and medical practitioners | Corporate Officer/Principal | - |
| MYRIAD GENETICS, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 4 |
|---|---|
Myriad Genetics, Inc.
Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
Tute Genomics, Inc.
Tute Genomics, Inc. Packaged SoftwareTechnology Services Develops and provides cloud-based application that delivers genomic insights to genetics research, clinicians and medical practitioners | Technology Services |
MediProPharma, Inc.
MediProPharma, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Omixon Biocomputing Kft
Omixon Biocomputing Kft Medical SpecialtiesHealth Technology Operates molecular diagnostics company that develops and commercializes disruptive technologies for clinical & research laboratories | Health Technology |
- Stock Market
- Insiders
- S. George Simon
















